Debt collection for Healthcare & Pharma.
Payment sits behind insurers, third-party administrators and hospital procurement cycles, so the delay is structural rather than a refusal to pay.
◆ As of 29 Jul 2026, 14:00 GST. Preview readings modelled from public sources — Atradius Payment Practices Barometer UAE 2025, CBUAE, S&P Global UAE PMI — and Wusala methodology. Live readings begin as Wusala's book and partner network report in.
Why healthcare & pharma invoices stall
Rejected or resubmitted claims, coding mismatches, formulary changes and expired credit approvals.
How we work a healthcare & pharma book
Split genuine insurer-side delay from hospital-side delay — they need different escalation
Chase resubmission deadlines before the claim window closes for good
Reconcile at batch level rather than invoice level to cut through the volume
Escalate to procurement and finance in parallel, not sequentially
The reason you haven't called them is the reason to let us.
Your largest overdue balance almost certainly belongs to a customer you cannot afford to lose. That is exactly why the invoice is still sitting there.
Every call is personal, every “next week” is one you have to accept, and every escalation has your face on it. So the call doesn’t get made.
The asking is done by a function whose only job is the ledger. You keep the relationship, the goodwill and the next order.
Every large company separates sales from credit control to protect the relationship. You don’t have that department. That’s what we are.
And you stay in charge of it:
- You name the accounts we never contact.
- Nothing goes out in your name without your approval of the wording.
- No legal step without your written instruction.
- We’ll tell you when a file isn’t worth pursuing.
Stopping the next one
Recovery gets yesterday’s money back. Keeping DSO down is a different discipline — and in healthcare & pharma it comes down to this: Track claim-rejection reasons as a leading indicator, and set credit limits per payer rather than per hospital group.
Healthcare & Pharma: common questions
What is a normal DSO for healthcare & pharma in the UAE?
Our current reading for healthcare & pharma is 74 days, against a national B2B average of 68 days. The sector runs about 6 days slower than the market, so a 74-day book is normal rather than alarming — but it is not healthy.
Why do healthcare & pharma invoices go unpaid?
Rejected or resubmitted claims, coding mismatches, formulary changes and expired credit approvals.
What does recovery cost?
The audit is free. Recovery fees are success-only and published: from 10% on current debt, rising to 25–35% for debt over a year old or disputed. You pay when we collect.
Can you stop this happening again?
Yes — that is what our Protect service does. Track claim-rejection reasons as a leading indicator, and set credit limits per payer rather than per hospital group. We also monitor the book for early-warning signals so slow payers are caught before they reach 90 days.
What’s recoverable in your book?
Free, 48 hours, no obligation — scored invoice by invoice.